TERAPET Reflects on an Inspiring PTCOG 64
For TERAPET, PTCOG 64 in Deauville represented much more than a congress participation. It was an important opportunity to reconnect with the global particle therapy community, strengthen existing collaborations, and discuss how in-vivo PET verification can help close the loop between planned and delivered treatment. Throughout the week, our team had the chance to meet […]
TERAPET at ESTRO 2026: From Plan to Proof in Upright Particle Therapy
For TERAPET, ESTRO 2026 represented far more than a congress participation. It marked our first presence at European Society for Radiation Oncology Annual meeting, the introduction of our newly rebranded identity, and an important opportunity to present our expanding portfolio of technologies to the international radiation oncology community. Throughout the week in Stockholm, we had […]
Fast Timing in Medical Imaging – Total Body PET – PET/SPECT and MR Multimodal Technologies 2026
Terapet to join FTMI-TBPET-PSMR 2026 as Platinum Sponsor Terapet will open the 2026 conference season at FTMI-TBPET-PSMR 2026, taking place from 11 to 14 May at Hotel Las Arenas in Valencia, Spain. The joint workshop brings together three major research areas in medical imaging: Fast Timing in Medical Imaging, Total-Body PET, and PET/SPECT and MR […]
Closing words on our Japanese mission 2025 from our CEO, Christina Vallgren
What an extraordinary journey these past days in Japan have been: intense, inspiring, and filled with moments that will shape the next phase of our work. Our mission started in Osaka, where we were welcomed by the Consulate of Switzerland, Swissnex in Japan. Their support was instrumental in navigating Japan’s innovation ecosystem and opening doors to […]
Closing words on PTCOG62 from our CEO : Christina Vallgren
Our second #PTCOG62 – one of the largest particle therapy congresses in the world, in Singapore last week ended with a huge accomplishment! An extremely busy but very successful exhibition. Thank you to everyone who showed your huge interest in our #Qualyscan, the world’s first end-to-end quality assurance device for particle therapy and our vision […]
Terapet, one of the sponsors at FARO-KOSRO, the largest Asian radiation oncology congresses, in Seoul, South Korea this year
Meet the Terapet SA team and learn more about the world’s first end-to-end quality assurance device, Qualyscan(R) for particle therapy in Seoul, South Korea at this year’s FARO-KOSRO (Federation of Asian Organizations for Radiation Oncology – the Korea Society for Radiation Oncology).We are proud of being this year’s bronze sponsor to one of the largest […]
Closing words on PTCOG61 from our CEO : Christina Vallgren
Our first #PTCOG61 ended with a huge accomplishment! An extremely busy yet very successful exhibition. Thank you to everyone who showed your huge interest in our first product, Qualyscan.I would like to thank my fantastic team who has worked so hard to bring our first product to our customers: Raymond Miralbell, Marcus Palm, Ben Brunt, […]